136 related articles for article (PubMed ID: 36919404)
21. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
Karsies TJ; Nicol KK; Galantowicz ME; Stephens JA; Kerlin BA
Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
[TBL] [Abstract][Full Text] [Related]
22. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
Li Y; Zhao W; Luo Q; Wu X; Ding J; Yan F
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
[TBL] [Abstract][Full Text] [Related]
23. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Tobias JD; Simsic JM; Weinstein S; Schechter W; Kartha V; Michler R
J Intensive Care Med; 2004; 19(5):270-3. PubMed ID: 15358945
[TBL] [Abstract][Full Text] [Related]
24. Recombinant activated factor VII in patients with acute liver failure with UNOS Status 1A: a single tertiary academic centre experience.
Pham HP; Hsu SX; Parker-Jones S; Samstein B; Diuguid D; Schwartz J
Vox Sang; 2014 Jan; 106(1):75-82. PubMed ID: 23815226
[TBL] [Abstract][Full Text] [Related]
25. Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?
Okonta KE; Edwin F; Falase B
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):690-4. PubMed ID: 22811512
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of recombinant activated factor VII in nonhemophilia children with severe or life-threatening bleeding: a report from the SeveNBleeP registry.
Blatný J; Mathew P; Monagle P; Ovesna P; Fiamoli V
Blood Coagul Fibrinolysis; 2014 Jun; 25(4):326-32. PubMed ID: 24389586
[TBL] [Abstract][Full Text] [Related]
27. Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient.
DeLoughery E; Avery B; DeLoughery TG
Am J Hematol; 2016 Jul; 91(7):705-8. PubMed ID: 27074566
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review.
Long MT; Wagner D; Maslach-Hubbard A; Pasko DA; Baldridge P; Annich GM
Perfusion; 2014 Mar; 29(2):163-70. PubMed ID: 23942787
[TBL] [Abstract][Full Text] [Related]
29. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
[TBL] [Abstract][Full Text] [Related]
30. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
McCall P; Story DA; Karalapillai D
Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
[TBL] [Abstract][Full Text] [Related]
31. Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass.
Percy CL; Hartmann R; Jones RM; Balachandran S; Mehta D; Dockal M; Scheiflinger F; O'Donnell VB; Hall JE; Collins PW
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):357-67. PubMed ID: 25928274
[TBL] [Abstract][Full Text] [Related]
32. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
[TBL] [Abstract][Full Text] [Related]
33. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
Guzzetta NA; Russell IA; Williams GD
Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
[TBL] [Abstract][Full Text] [Related]
34. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
35. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Low Dose Recombinant Factor VIIa and 4-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Cardiac Surgery.
Caldwell L; Bhakta R; Naik N; Knowles BD; Parker J; Van Berkel Patel M
J Pharm Pract; 2024 Jan; ():8971900241228766. PubMed ID: 38261533
[No Abstract] [Full Text] [Related]
37. Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience.
Bhat S; Yadav SP; Anjan M; Dinand V; Sachdeva A
Indian J Pediatr; 2011 Aug; 78(8):961-8. PubMed ID: 21328080
[TBL] [Abstract][Full Text] [Related]
38. Activated 4-Factor Prothrombin Complex Concentrate as a Hemostatic Adjunct for Neonatal Cardiac Surgery: A Propensity Score-Matched Cohort Study.
Navaratnam M; Mendoza JM; Zhang S; Boothroyd D; Maeda K; Kamra K; Williams GD
Anesth Analg; 2023 Mar; 136(3):473-482. PubMed ID: 36729967
[TBL] [Abstract][Full Text] [Related]
39. Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII.
Pinner NA; Hurdle AC; Oliphant C; Reaves A; Lobo B; Sills A
World Neurosurg; 2010 Dec; 74(6):631-5. PubMed ID: 21492631
[TBL] [Abstract][Full Text] [Related]
40. Recombinant activated factor VII use in critically ill infants with active hemorrhage.
Jen H; Shew S
J Pediatr Surg; 2008 Dec; 43(12):2235-8. PubMed ID: 19040942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
